Alpha-1 antitrypsin deficiency: A conformational disease associated with lung and liver manifestations
✍ Scribed by C. M. Greene; S. D. W. Miller; T. Carroll; C. McLean; M. O’Mahony; M. W. Lawless; S. J. O’Neill; C. C. Taggart; N. G. McElvaney
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 489 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In recent years, we have witnessed several important paradigm shifts in understanding the molecular basis of liver disease in alpha-1-antitrypsin (AT) deficiency. These shifts have become possible as a result of a number of advances in research on the cell biology of aggregation-prone mutant protein
Liver disease in alpha-1-antitrypsin (alpha1AT) deficiency is caused by a gain-of-toxic function mechanism engendered by the accumulation of a mutant glycoprotein in the endoplasmic reticulum (ER). The extraordinary degree of variation in phenotypical expression of this liver disease is believed to
Chronic liver disease affects up to 20% of children with alpha 1-antitrypsin deficiency owing to the PiZZ genotype. Previous observations of a familial occurrence and abnormal immune responses to liver antigens in these patients suggests that immunoregulatory genes may be involved in the pathogenesi